ZA852086B - S(-)-3-(3-acetyl-4-(3-tert.butylamino-2-hydroxypropoxy)-phenyl)-1,1-diethylurea,its pharmaceutically tolerated salts,production process and pharmaceutical formulations - Google Patents

S(-)-3-(3-acetyl-4-(3-tert.butylamino-2-hydroxypropoxy)-phenyl)-1,1-diethylurea,its pharmaceutically tolerated salts,production process and pharmaceutical formulations

Info

Publication number
ZA852086B
ZA852086B ZA852086A ZA852086A ZA852086B ZA 852086 B ZA852086 B ZA 852086B ZA 852086 A ZA852086 A ZA 852086A ZA 852086 A ZA852086 A ZA 852086A ZA 852086 B ZA852086 B ZA 852086B
Authority
ZA
South Africa
Prior art keywords
diethylurea
acetyl
phenyl
hydroxypropoxy
butylamino
Prior art date
Application number
ZA852086A
Other languages
English (en)
Inventor
Gerhard Zoelb
Richard Gratz
Karl Schloegl
Otmar Hofer
Robert Jay Gordon
Original Assignee
Chemie Linz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemie Linz Ag filed Critical Chemie Linz Ag
Publication of ZA852086B publication Critical patent/ZA852086B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Epoxy Compounds (AREA)
ZA852086A 1984-03-21 1985-03-20 S(-)-3-(3-acetyl-4-(3-tert.butylamino-2-hydroxypropoxy)-phenyl)-1,1-diethylurea,its pharmaceutically tolerated salts,production process and pharmaceutical formulations ZA852086B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843410380 DE3410380A1 (de) 1984-03-21 1984-03-21 S(-)-celiprolol, dessen pharmazeutisch vertraegliche salze, verfahren zu dessen herstellung, verwendung in der therapie und pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
ZA852086B true ZA852086B (en) 1985-11-27

Family

ID=6231193

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA852086A ZA852086B (en) 1984-03-21 1985-03-20 S(-)-3-(3-acetyl-4-(3-tert.butylamino-2-hydroxypropoxy)-phenyl)-1,1-diethylurea,its pharmaceutically tolerated salts,production process and pharmaceutical formulations

Country Status (21)

Country Link
EP (1) EP0155518B1 (fr)
JP (1) JPS60209557A (fr)
AT (1) ATE45945T1 (fr)
AU (1) AU567797B2 (fr)
CA (1) CA1236116A (fr)
CS (2) CS250683B2 (fr)
DD (2) DD234860A1 (fr)
DE (2) DE3410380A1 (fr)
DK (1) DK124585A (fr)
ES (1) ES8603390A1 (fr)
FI (1) FI83636C (fr)
GR (1) GR850496B (fr)
HU (1) HU193596B (fr)
IL (1) IL74383A (fr)
NO (1) NO161254C (fr)
PL (2) PL143883B1 (fr)
PT (1) PT80135B (fr)
RO (2) RO91353B (fr)
SU (2) SU1309908A3 (fr)
YU (2) YU45246B (fr)
ZA (1) ZA852086B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3636209A1 (de) * 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
AT388099B (de) * 1986-11-26 1989-04-25 Chemie Holding Ag Verfahren zur hestellung von festen arzneiformen von (3-(3-acetyl-4-(3-tert. butylamino-2-hydroxypropoxy)-phenyl)-1,1-diethylharnstoff)- hydrochlorid
US4931557A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
EP0423484B1 (fr) * 1989-10-16 1993-11-03 PCD-Polymere Gesellschaft m.b.H. Comprimé à libération retardée
DE3935736A1 (de) * 1989-10-27 1991-05-02 Chemie Linz Deutschland Pressling mit retardierter wirkstofffreisetzung
US5227526A (en) * 1992-06-16 1993-07-13 Mallinckrodt Specialty Chemicals Company Resolution of 3-dimethylamino-2-methylpropiophenone (3-DAMP)
CN101239937B (zh) * 2007-02-07 2010-05-19 上海雅本化学有限公司 一种光学活性r-(-)-1-苄氧羰基-3-氨基吡咯烷及其盐酸盐的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU170678B (fr) * 1973-12-20 1977-08-28
AT334385B (de) * 1973-12-20 1976-01-10 Chemie Linz Ag Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen
HU170677B (fr) * 1973-12-21 1977-08-28
US4470965A (en) * 1982-10-27 1984-09-11 Usv Pharmaceutical Corporation Celiprolol for the treatment of glaucoma

Also Published As

Publication number Publication date
PT80135A (de) 1985-04-01
DE3572656D1 (en) 1989-10-05
CS250682B2 (en) 1987-05-14
SU1309908A3 (ru) 1987-05-07
EP0155518A3 (en) 1986-06-25
IL74383A0 (en) 1985-05-31
DK124585D0 (da) 1985-03-20
ES541424A0 (es) 1985-12-16
DK124585A (da) 1985-09-22
FI83636C (fi) 1991-08-12
PL252463A1 (en) 1985-11-19
RO91353B (ro) 1987-05-01
YU45246B (en) 1992-05-28
DD234860A1 (de) 1986-04-16
IL74383A (en) 1988-09-30
YU44385A (en) 1987-06-30
PT80135B (pt) 1987-10-20
AU567797B2 (en) 1987-12-03
FI850860L (fi) 1985-09-22
ES8603390A1 (es) 1985-12-16
HU193596B (en) 1987-11-30
NO850834L (no) 1985-09-23
FI83636B (fi) 1991-04-30
RO91352B (ro) 1987-05-02
YU45707B (sh) 1992-07-20
CA1236116A (fr) 1988-05-03
RO91353A (fr) 1987-04-30
HUT37392A (en) 1985-12-28
DE3410380A1 (de) 1985-10-10
CS250683B2 (en) 1987-05-14
ATE45945T1 (de) 1989-09-15
DD232489A1 (de) 1986-01-29
GR850496B (fr) 1985-03-15
EP0155518A2 (fr) 1985-09-25
PL252462A1 (en) 1985-11-19
FI850860A0 (fi) 1985-03-04
RO91352A (fr) 1987-04-30
PL143883B1 (en) 1988-03-31
EP0155518B1 (fr) 1989-08-30
YU44485A (en) 1987-06-30
AU3972285A (en) 1985-09-26
SU1333235A3 (ru) 1987-08-23
JPS60209557A (ja) 1985-10-22
NO161254C (no) 1989-07-26
NO161254B (no) 1989-04-17

Similar Documents

Publication Publication Date Title
HUT42080A (en) Process for producing labdane derivatives and pharmaceutical compositions containing them
ZA852086B (en) S(-)-3-(3-acetyl-4-(3-tert.butylamino-2-hydroxypropoxy)-phenyl)-1,1-diethylurea,its pharmaceutically tolerated salts,production process and pharmaceutical formulations
FR2381777A1 (fr) Procede de preparation d'oxazolinoazetidinones a partir d'acide 6-aminopenicillanique et nouveaux produits ainsi obtenus
PT84597A (en) Process for the preparation of compositions for increasing crop yield containing malonic acid derivatives as well as of novel malonic acid derivatives
FR2444673A1 (fr) Nouvelles trifluoroethylamines, leurs procedes d'obtention et leur emploi comme medicament
FR2390422A1 (fr) Nouveaux 1-acyl-2-hydroxy-1,3-diaminopropanes, leur procede d'obtention et leur application comme medicaments
EP0273316A3 (en) Stereoconvergent process for preparing optically active carboxylic acids
BR8707026A (pt) Composicao fungicida,composto,enantiomero,racemato,mistura,processo para a preparacao de par de enantiomeros e processo para combater microorganismos nocivos as plantas
DE3378980D1 (en) Benzazepine derivatives, process for their preparation and their use as pharmaceutical compounds
FR2370052A1 (fr) Lactames utiles notamment comme medicaments et leur procede de preparation
DE3169365D1 (en) Indolo-naphthyridines and their use as medicaments
DE3071497D1 (en) 2-penem compounds; a method for their preparation and pharmaceutical compositions comprising them
EP0134245A4 (fr) Procede de preparation de 3-chloro-1-formyl-4-phenyl-pyrroles.
FR2432505A1 (fr) Nouveaux sels de 5-iodo-3-nitro-4-hydroxybenzonitrile, leur preparation et compositions qui les contiennent
JPS5455506A (en) Preparation of polyprenyl alcohol
JPH03178970A (ja) 2―芳香族―3―ハロベンゾチアゼピン類